Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Am J Prev Med. 2021 Dec 8;62(3):367–376. doi: 10.1016/j.amepre.2021.08.015

Figure 1.

Figure 1.

Population attributable fraction of vaccine hesitancy on undervaccination, April–June 2018 and 2019, NIS-Child.

aUTD defined as ≥3 rotavirus doses of any type or ≥2 Rotarix doses.

bThe combined 7-vaccine series (4:3:1:3*: 3:1:4) includes ≥4 doses of DTaP, ≥3 doses of IPV, ≥1 dose of MMR, the full series of Hib (≥3 or ≥4 doses, depending on product type), ≥3 doses of HepB, ≥1 dose of VAR, and ≥4 doses of PCV.

DTaP, diphtheria, tetanus toxoid, and acellular pertussis vaccine; HepB, hepatitis B vaccine; Hib, Haemophilus influenzae type b conjugate vaccine; IPV, inactivated polio vaccine; MMR, measles, mumps, and rubella vaccine; NIS, National Immunization Survey; PCV, pneumococcal conjugate vaccine; UTD, up-to-date; VAR, varicella vaccine.